NCT06050551

Brief Summary

This study aims to figure out how small-bore pigtail catheter or large-bore chest tube for postoperative drainage impact on analgesic efficacy and actually enhance recovery postoperatively.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 8, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 26, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

September 22, 2023

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

September 22, 2023

Status Verified

September 1, 2023

Enrollment Period

1.7 years

First QC Date

August 26, 2023

Last Update Submit

September 21, 2023

Conditions

Keywords

post-operative analgesiaERAS (Enhanced Recovery After Surgery)pigtailchest tube

Outcome Measures

Primary Outcomes (3)

  • The VAS (Visual Analogue Scale)

    resting and dynamic VAS (Visual Analogue Scale) while coughing and ambulation, the scale from "0" to "10", depending on the severity of pain. "0" means not painful, and "10" means the most pain in whole life.

    after operation 0, 2, 4, 8, 24, 48 hours

  • morphine usage

    cumulative intravenous morphine consumption

    in the first 24 hours after operation,

  • if there is any episodes of nausea or vomiting episodes that needs mediaction

    related to anesthesia or analgesia.

    after operation 0, 2, 4, 8, 24, 48 hours

Secondary Outcomes (3)

  • pleural drainage from chest tube or pigtail, which was recorded by nurse.

    after operation 24, 48, 72, 96 hours

  • if there is any timepoint for need of conversion to tube thoracotomy from pigtail catheter

    after operation 24, 48, 72, 96 hours

  • post-operative care after uniportal VATS (Video-Assisted Thoracic Surgery)

    after operation 24, 48, 72, 96 hours

Study Arms (2)

14-Fr pigtail catheter after uniportal VATS

EXPERIMENTAL

smaller catheter used after uniportal VATS

Procedure: uniportal VATS

20-Fr chest tube after uniportal VATS

OTHER

routine management after uniportal VATS

Procedure: uniportal VATS

Interventions

1. elective uniportal VATS lung resection, pleural tumor removal or mediastinal lymph node biopsy, etc. (exclude the bil. operation, extended wound length over 5 cm, conversion to thoracotomy or multiportal VATS procedure, surgeon's decision for exclusion during operation.) 2. thoracoscopic internal costal nerve block with 10 mL of 1% Ropivacaine at the end of the operation, 3. routinely prescribed with oral Tramadol 37.5mg and Acetaminophen 325mg four times a day postoperatively and intravenous morphine as extra dose if need.

14-Fr pigtail catheter after uniportal VATS20-Fr chest tube after uniportal VATS

Eligibility Criteria

Age20 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- eighty consecutive adult patients undergoing elective uniportal VATS lobectomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yuan's General Hospital

Kaohsiung City, 806, Taiwan

RECRUITING

MeSH Terms

Conditions

Pain, PostoperativePostoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
medical doctor, attending physician

Study Record Dates

First Submitted

August 26, 2023

First Posted

September 22, 2023

Study Start

March 8, 2023

Primary Completion

November 1, 2024

Study Completion

December 1, 2024

Last Updated

September 22, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations